AU1810899A - Neuropilins and use thereof in methods for diagnosis and prognosis of cancer - Google Patents

Neuropilins and use thereof in methods for diagnosis and prognosis of cancer

Info

Publication number: AU1810899A
Authority: AU; Australia
Prior art keywords: neuropilins; prognosis; diagnosis; cancer; methods
Prior art date: 1997-12-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU18108/99A

Inventor

Michael Klagsbrun

Hua-Quan Miao

Shay Soker

Seiji Takashima

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boston Childrens Hospital

Original Assignee

Boston Childrens Hospital

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-09

Filing date

1998-12-09

Publication date

1999-06-28

1998-12-09 Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital

1999-06-28 Publication of AU1810899A publication Critical patent/AU1810899A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Gastroenterology & Hepatology (AREA)
Cardiology (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Zoology (AREA)
Heart & Thoracic Surgery (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU18108/99A 1997-12-09 1998-12-09 Neuropilins and use thereof in methods for diagnosis and prognosis of cancer Abandoned AU1810899A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US6915597P	1997-12-09	1997-12-09
US60069155		1997-12-09
US6968797P	1997-12-12	1997-12-12
US60069687		1997-12-12
PCT/US1998/026127 WO1999030157A2 (en)	1997-12-09	1998-12-09	Neuropilins in methods for diagnosis and prognosis of cancer

Publications (1)

Publication Number	Publication Date
AU1810899A true AU1810899A (en)	1999-06-28

Family

ID=26749747

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU19060/99A Abandoned AU1906099A (en)	1997-12-09	1998-12-09	Peptide antagonists of vascular endothelial growth factor
AU18108/99A Abandoned AU1810899A (en)	1997-12-09	1998-12-09	Neuropilins and use thereof in methods for diagnosis and prognosis of cancer

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU19060/99A Abandoned AU1906099A (en)	1997-12-09	1998-12-09	Peptide antagonists of vascular endothelial growth factor

Country Status (5)

Country	Link
EP (1)	EP1037994A1 (en)
JP (2)	JP4312955B2 (en)
AU (2)	AU1906099A (en)
CA (1)	CA2313390A1 (en)
WO (2)	WO1999029861A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7727761B2 (en)	1995-08-01	2010-06-01	Vegenics Limited	Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
US6635421B1 (en) *	1997-12-09	2003-10-21	Children's Medical Center Corporation	Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
EP1248642A4 (en) *	2000-01-18	2005-05-18	Ludwig Inst Cancer Res	PEPTIDOMIMETIC INHIBITOR OF VEGF AND VEGF-C AND -D
ATE377081T1 (en)	2000-02-25	2007-11-15	Ludwig Inst Cancer Res	MATERIALS AND METHODS CONTAINING HYBRID VASCULAR DOTHELIAL GROWTH FACTORS DNA AND PROTEINS AND SCREENING METHODS FOR MODULATORS
US8263739B2 (en)	2000-06-02	2012-09-11	Bracco Suisse Sa	Compounds for targeting endothelial cells, compositions containing the same and methods for their use
EP2279757A3 (en)	2000-06-02	2011-08-03	Bracco Suisse SA	Compounds for targeting endothelial cells
WO2002020813A2 (en) *	2000-09-05	2002-03-14	Karolinska Innovations Ab	Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
GB0029015D0 (en)	2000-11-28	2001-01-10	Univ London	Medical device
US7611711B2 (en)	2001-01-17	2009-11-03	Vegenics Limited	VEGFR-3 inhibitor materials and methods
US8623822B2 (en)	2002-03-01	2014-01-07	Bracco Suisse Sa	KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
CA2513044A1 (en)	2002-03-01	2004-08-05	Dyax Corp.	Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7794693B2 (en)	2002-03-01	2010-09-14	Bracco International B.V.	Targeting vector-phospholipid conjugates
US7261876B2 (en)	2002-03-01	2007-08-28	Bracco International Bv	Multivalent constructs for therapeutic and diagnostic applications
GB0207644D0 (en) *	2002-04-02	2002-05-15	Ark Therapeutics Ltd	Peptides and their use
AU2004217894B2 (en)	2003-03-03	2010-07-15	Bracco International B.V.	Peptides that specifically bind HGF receptor (cMet) and uses thereof
CA2615636A1 (en) *	2005-08-12	2007-02-22	Regeneron Pharmaceuticals, Inc.	Treatment of diseases by subcutaneous administration of a vegf antagonist
ATE502956T1 (en)	2005-08-15	2011-04-15	Vegenics Pty Ltd	MODIFIED VEGF AND PDGF WITH IMPROVED ANGIOGENIC PROPERTIES
RU2395090C2 (en) *	2005-10-21	2010-07-20	БАЙЕР ХелсКер ЛЛСи	Methods of forecasting and prediction of cancer and control on therapy of cancer
UA96139C2 (en)	2005-11-08	2011-10-10	Дженентек, Інк.	Anti-neuropilin-1 (nrp1) antibody
AU2011206104A1 (en) *	2010-01-14	2012-07-12	Nagoya City University	Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
BR112013000340A2 (en)	2010-07-09	2016-05-31	Genentech Inc	isolated antibody that binds neuropillin-1 (nrp1), isolated nucleic acid, host cell, method of producing an antibody, immunoconjugate and method of detecting nrp1 in a biological sample
AU2019247511A1 (en)	2018-04-06	2020-10-22	Atyr Pharma, Inc.	Compositions and methods comprising anti-NRP2 antibodies
US11807687B2 (en)	2019-10-03	2023-11-07	Atyr Pharma, Inc.	Therapeutic compositions comprising anti-NRP2 antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1701814A (en) *	1992-11-13	2005-11-30	马克斯普朗克科学促进协会	F1K-1 is a receptor for vascular endothelial growth factor
US6020473A (en) *	1995-08-25	2000-02-01	Genentech, Inc.	Nucleic acids encoding variants of vascular endothelial cell growth factor

1998
- 1998-12-09 EP EP98963815A patent/EP1037994A1/en not_active Withdrawn
- 1998-12-09 WO PCT/US1998/026103 patent/WO1999029861A1/en not_active Application Discontinuation
- 1998-12-09 WO PCT/US1998/026127 patent/WO1999030157A2/en active Application Filing
- 1998-12-09 AU AU19060/99A patent/AU1906099A/en not_active Abandoned
- 1998-12-09 CA CA002313390A patent/CA2313390A1/en not_active Abandoned
- 1998-12-09 JP JP2000524433A patent/JP4312955B2/en not_active Expired - Lifetime
- 1998-12-09 AU AU18108/99A patent/AU1810899A/en not_active Abandoned
2009
- 2009-03-05 JP JP2009052725A patent/JP2009148293A/en not_active Withdrawn

Also Published As

Publication number	Publication date
WO1999030157A9 (en)	1999-10-21
AU1906099A (en)	1999-06-28
JP2001526032A (en)	2001-12-18
WO1999030157A2 (en)	1999-06-17
EP1037994A1 (en)	2000-09-27
WO1999029861A1 (en)	1999-06-17
JP2009148293A (en)	2009-07-09
JP4312955B2 (en)	2009-08-12
WO1999030157A3 (en)	1999-07-22
CA2313390A1 (en)	1999-06-17

Publication	Publication Date	Title
AU1810899A (en)	1999-06-28	Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
AU1931899A (en)	1999-07-05	Optoacoustic contrast agents and methods for their use
AU2010699A (en)	1999-07-19	Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
AU6492798A (en)	1998-10-20	Microscope slide system and method of use
AU1807300A (en)	2000-05-15	Detection of loss of heterozygosity in tumor and serum of melanoma patients
AU5155398A (en)	1998-05-22	Anti-ccr5 antibodies and methods of use therefor
AU6148898A (en)	1998-08-25	2-substituted 7-haloindenes and methods for synthesizing
AU2160297A (en)	1997-10-22	Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
AU3182999A (en)	1999-09-27	Methods of diagnosis and triage using cell activation measures
AU6468998A (en)	1998-10-12	Compositions and method for the early diagnosis of ovarian cancer
EP1144632A3 (en)	2001-11-07	Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU1465801A (en)	2001-05-14	Methods for cancer prognosis and diagnosis
AU2582195A (en)	1995-12-05	Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
AU1132595A (en)	1996-04-18	Chromosome 18q loss and prognosis in colorectal cancer
AU1575697A (en)	1997-08-01	Compositions and methods for the treatment and diagnosis of cancer
AU3159499A (en)	1999-10-18	Antigen preparation and use
AU4003597A (en)	1998-03-26	Methods of diagnosing and treating cancer
AU5543494A (en)	1994-05-24	Method and kit for cancer diagnosis
AU9301998A (en)	1999-03-22	Composition and methods using galectin-1
EP0965840A4 (en)	2001-10-31	Method for analyzing annexin v in urine and use thereof
AU4150999A (en)	2000-01-05	Method and kit for early diagnosis of cancer
AU1538497A (en)	1997-08-28	Anti-gp46 antibodies and fragments thereof and their use
AU1763097A (en)	1997-09-16	Detection of prostate-specific antigen in breast tumors and serum
EP0794174A3 (en)	1997-11-19	Labeled reagents for use in immunoassays and fluorescent compounds and complexes used therein
AU9018598A (en)	1999-03-08	Prognostic compositions for prostate cancer and methods of use thereof

Legal Events

Date	Code	Title	Description
2000-08-24	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase